| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |